Cheng Sohanya Roshan - Insider Non-Derivative Transactions at Karyopharm Therapeutics Inc. (KPTI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 4, 2024, Cheng Sohanya Roshan's relationship to Karyopharm Therapeutics Inc. (KPTI) is Officer (EVP & Chief Commercial Officer), and currently has 404,051 shares of Common Stock, and 393,509 shares of Common.

The the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KPTI insiders.

Data Source: SEC.
Cheng Sohanya Roshan - Insider Non-Derivative Transactions of KPTI Common Stock
Cheng Sohanya Roshan - Insider Non-Derivative Transactions of KPTI Common
Cheng Sohanya Roshan - Insider Non-Derivative Transactions at KPTI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 5, 2024 Sell -- (Common Stock) 5356 0.72 404051
Mar 2, 2024 Sell -- (Common) 5109 1.2 393509
Mar 1, 2024 Sell -- (Common) 21840 1.17 398618
Feb 29, 2024 Acquisition -- (Common Stock) 198959 0 420458
Jan 25, 2024 Acquisition -- (Common Stock) 14167 0 221499
Sep 2, 2023 Sell -- (Common Stock) 7415 1.33 204086
Jun 9, 2023 Sell -- (Common Stock) 1839 2.35 211501
Mar 2, 2023 Sell -- (Common Stock) 11239 3.03 210687
Mar 1, 2023 Acquisition -- (Common Stock) 100000 0 221926